By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) 

245 First Street
Suite 1800
Cambridge  Massachusetts  02142  U.S.A.
Phone: 503-227-0554 Fax: 503-227-0751


SEARCH JOBS


Industry
Biotechnology






Company News
BioMarin (BMRN), Sarepta (SRPT) Rivalry Gets Nasty in Battle Over Data 1/19/2015 6:07:38 AM
Sarepta (SRPT) Announces First Patient Dosed In European Phase1/2 Study Of SRP-4053 In Duchenne Muscular Dystrophy Patients 1/14/2015 7:56:48 AM
Breaking: J.P. Morgan: BioMarin (BMRN) Takes Shot at Sarepta (SRPT), Says DMD Drug Has Better Results So Far 1/12/2015 5:12:05 PM
Sarepta Therapeutics (SRPT) Reports Long-Term Outcomes Through 168 Weeks From Phase 2b Study Of Eteplirsen In Duchenne Muscular Dystrophy 1/12/2015 12:10:20 PM
Sarepta Therapeutics (SRPT) To Present Company Overview At The 2015 33rd Annual J.P. Morgan Healthcare Conference 1/5/2015 9:19:14 AM
Ex-Sarepta Therapeutics (SRPT) Exec to Head Massachusetts Startup Checkmate Pharmaceuticals 12/30/2014 6:19:33 AM
Sarepta Therapeutics (SRPT) To Present Company Overview At Upcoming Conferences 11/24/2014 10:45:17 AM
Sarepta Therapeutics (SRPT) Announces First Patient Dosed In Confirmatory Study Of Eteplirsen In Ambulant Patients With Duchenne Muscular Dystrophy 11/18/2014 9:21:35 AM
Sarepta Therapeutics (SRPT) Announces First Patient Dosed In Study Of Eteplirsen In Non-Ambulant Patients With Duchenne Muscular Dystrophy 11/13/2014 10:56:57 AM
Sarepta Therapeutics (SRPT) Announces Third Quarter 2014 Financial Results and Recent Corporate Developments 11/6/2014 1:37:54 PM
12345678910...
//-->